Provepharm Inc.

PA · United States · Reporting entity ID 100000186750

Total reported 2019–2025

$4.42M

#750 of 2,960 reporting companies — 0% of all reported industry payments

$410K in general payments across 416 records, plus $4.01M in research funding across 242 records.

How it breaks down

General payments $409,914

Research funding $4,013,873

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.